NOV (NOV) Stock Forecast, Price Target & Predictions
NOV Stock Forecast
NOV stock forecast is as follows: an average price target of $19.00 (represents a 19.80% upside from NOV’s last price of $15.86) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.
NOV Price Target
The average price target for NOV (NOV) is $19.00 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $29.00 to $12.00. This represents a potential 19.80% upside from NOV's last price of $15.86.
NOV Analyst Ratings
According to 8 Wall Street analysts, NOV's rating consensus is 'Buy'. The analyst rating breakdown for NOV stock is 0 'Strong Buy' (0.00%), 4 'Buy' (50.00%), 2 'Hold' (25.00%), 2 'Sell' (25.00%), and 0 'Strong Sell' (0.00%).
NOV Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 30, 2024 | David Anderson | Barclays | $20.00 | $19.81 | 0.96% | 26.10% |
| Feb 08, 2023 | - | Susquehanna | $29.00 | $23.30 | 24.44% | 82.85% |
| Jul 29, 2022 | - | Morgan Stanley | $19.00 | $17.53 | 8.39% | 19.80% |
| Jul 13, 2022 | - | Morgan Stanley | $18.00 | $14.72 | 22.24% | 13.49% |
| Jul 13, 2022 | - | Goldman Sachs | $16.00 | $14.88 | 7.53% | 0.88% |
| Jun 08, 2022 | - | Barclays | $22.00 | $21.45 | 2.56% | 38.71% |
| May 02, 2022 | - | Barclays | $20.00 | $18.68 | 7.07% | 26.10% |
| Feb 04, 2022 | James West | Evercore ISI | $22.00 | $16.17 | 36.05% | 38.71% |
| Dec 09, 2021 | Marc Bianchi | Cowen & Co. | $19.00 | $13.49 | 40.85% | 19.80% |
| Oct 11, 2021 | Connor Lynagh | Morgan Stanley | $17.00 | $14.43 | 17.81% | 7.19% |
The latest NOV stock forecast, released on Jul 30, 2024 by David Anderson from Barclays, set a price target of $20.00, which represents a 0.96% increase from the stock price at the time of the forecast ($19.81), and a 26.10% increase from NOV last price ($15.86).
NOV Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $20.00 | $20.00 |
| Last Closing Price | $15.86 | $15.86 | $15.86 |
| Upside/Downside | -100.00% | 26.10% | 26.10% |
In the current month, the average price target of NOV stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to NOV's last price of $15.86. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jul 30, 2024 | Barclays | Underweight | Underweight | Hold |
| Jul 29, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Apr 29, 2024 | Susquehanna | Sector Perform | Sector Perform | Hold |
| Apr 29, 2024 | RBC Capital | Underperform | Underperform | Hold |
| Apr 08, 2024 | RBC Capital | Underperform | Underperform | Hold |
| Apr 08, 2024 | Susquehanna | Sector Perform | Sector Perform | Hold |
| Feb 20, 2024 | Piper Sandler | Neutral | Neutral | Hold |
| Feb 06, 2024 | Raymond James | Underperform | Underperform | Hold |
| Feb 06, 2024 | RBC Capital | Sector Perform | Sector Perform | Hold |
| Oct 30, 2023 | Raymond James | Outperform | Outperform | Hold |
NOV's last stock rating was published by Barclays on Jul 30, 2024. The company gave NOV a "Underweight" rating, the same as its previous rate.
NOV Financial Forecast
NOV Revenue Forecast
| Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.34B | $2.19B | $2.09B | $1.96B | $2.07B | $1.89B | - | $1.55B | $1.52B | $1.34B |
| Avg Forecast | $2.53B | $2.51B | $2.49B | $2.48B | $2.46B | $2.44B | $2.42B | $2.40B | $2.72B | $2.53B | $2.46B | $2.38B | $2.53B | $2.39B | $2.34B | $2.26B | $2.38B | $2.24B | $2.19B | $2.11B | $2.26B | $2.13B | $2.07B | $1.96B | $1.96B | $1.82B | $1.64B | $1.53B | $1.46B | $1.42B |
| High Forecast | $2.64B | $2.62B | $2.60B | $2.58B | $2.57B | $2.55B | $2.53B | $2.51B | $2.84B | $2.64B | $2.57B | $2.48B | $2.64B | $2.49B | $2.44B | $2.36B | $2.48B | $2.34B | $2.28B | $2.20B | $2.29B | $2.15B | $2.16B | $2.05B | $2.04B | $1.90B | $1.64B | $1.58B | $1.51B | $1.47B |
| Low Forecast | $2.49B | $2.47B | $2.46B | $2.44B | $2.42B | $2.40B | $2.38B | $2.37B | $2.68B | $2.49B | $2.42B | $2.34B | $2.49B | $2.35B | $2.30B | $2.23B | $2.34B | $2.20B | $2.15B | $2.08B | $2.25B | $2.04B | $2.04B | $1.93B | $1.93B | $1.79B | $1.64B | $1.50B | $1.44B | $1.40B |
| # Analysts | 6 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 9 | 19 | 18 | 9 | 8 | 8 | 12 | 16 | 18 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 1.03% | 1.01% | 1.00% | 1.06% | 1.04% | - | 1.01% | 1.04% | 0.94% |
NOV's average Quarter revenue forecast for Mar 24 based on 4 analysts is $2.11B, with a low forecast of $2.08B, and a high forecast of $2.20B. NOV's average Quarter revenue forecast represents a -9.98% decrease compared to the company's last Quarter revenue of $2.34B (Dec 23).
NOV EBITDA Forecast
| Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 9 | 19 | 18 | 9 | 8 | 8 | 12 | 16 | 18 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $161.00M | $183.00M | $181.00M | $235.00M | $231.00M | $159.00M | - | $58.00M | $46.00M | $30.00M |
| Avg Forecast | $72.89M | $72.36M | $71.83M | $71.30M | $70.77M | $70.25M | $69.74M | $69.22M | $78.48M | $72.80M | $70.94M | $68.52M | $72.92M | $68.72M | $67.36M | $65.20M | $68.50M | $64.47M | $63.01M | $96.73M | $65.13M | $61.29M | $59.64M | $87.94M | $56.34M | $17.53M | $47.10M | $94.05M | $30.67M | $18.75M |
| High Forecast | $76.11M | $75.55M | $74.99M | $74.44M | $73.89M | $73.35M | $72.81M | $72.27M | $81.94M | $76.01M | $74.07M | $71.54M | $76.13M | $71.74M | $70.33M | $68.08M | $71.52M | $67.34M | $65.79M | $116.08M | $65.99M | $61.85M | $62.27M | $105.52M | $58.83M | $21.04M | $47.10M | $112.86M | $36.80M | $22.50M |
| Low Forecast | $71.76M | $71.23M | $70.71M | $70.19M | $69.67M | $69.16M | $68.65M | $68.15M | $77.26M | $71.67M | $69.84M | $67.45M | $71.78M | $67.65M | $66.31M | $64.19M | $67.43M | $63.33M | $62.03M | $77.38M | $64.84M | $58.77M | $58.71M | $70.35M | $55.47M | $14.03M | $47.10M | $75.24M | $24.53M | $15.00M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.47% | 2.99% | 3.03% | 2.67% | 4.10% | 9.07% | - | 0.62% | 1.50% | 1.60% |
4 analysts predict NOV's average Quarter EBITDA for Mar 24 to be $96.73M, with a high of $116.08M and a low of $77.38M. This is -39.92% lower than NOV's previous annual EBITDA (Dec 23) of $161.00M.
NOV Net Income Forecast
| Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 9 | 19 | 18 | 9 | 8 | 8 | 12 | 16 | 18 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $598.00M | $114.00M | $155.00M | $126.00M | $104.00M | $32.00M | - | $-49.00M | $-43.00M | $-69.00M |
| Avg Forecast | $224.58M | $221.49M | $211.32M | $200.05M | $212.12M | $209.42M | $200.09M | $183.85M | $244.87M | $212.74M | $201.75M | $185.77M | $213.45M | $182.65M | $169.54M | $148.57M | $175.63M | $145.92M | $137.51M | $-84.85M | $164.19M | $138.22M | $116.70M | $-77.14M | $90.83M | $-40.32M | $16.79M | $-82.50M | $-28.67M | $-43.13M |
| High Forecast | $237.45M | $234.17M | $223.43M | $211.51M | $224.27M | $221.41M | $211.55M | $194.38M | $258.90M | $224.93M | $213.31M | $196.41M | $225.68M | $193.11M | $179.26M | $157.08M | $185.70M | $185.36M | $145.39M | $-67.88M | $176.20M | $191.07M | $123.39M | $-61.71M | $96.03M | $-32.26M | $16.79M | $-66.00M | $-22.93M | $-34.50M |
| Low Forecast | $220.04M | $217.00M | $207.05M | $196.00M | $207.83M | $205.18M | $196.04M | $180.13M | $239.92M | $208.44M | $197.67M | $182.01M | $209.13M | $178.95M | $166.11M | $145.56M | $172.08M | $126.20M | $134.73M | $-101.82M | $152.18M | $113.83M | $114.34M | $-92.56M | $88.99M | $-48.39M | $16.79M | $-99.00M | $-34.40M | $-51.75M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.64% | 0.82% | 1.33% | -1.63% | 1.15% | -0.79% | - | 0.59% | 1.50% | 1.60% |
NOV's average Quarter net income forecast for Mar 24 is $-84.85M, with a range of $-101.82M to $-67.88M. NOV's average Quarter net income forecast represents a -114.19% decrease compared to the company's last Quarter net income of $598.00M (Dec 23).
NOV SG&A Forecast
| Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 9 | 19 | 18 | 9 | 8 | 8 | 12 | 16 | 18 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $336.00M | $285.00M | $276.00M | $285.00M | $281.00M | $313.00M | - | $235.00M | $217.00M | $228.00M |
| Avg Forecast | $386.09M | $383.25M | $380.43M | $377.63M | $374.85M | $372.10M | $369.36M | $366.64M | $415.66M | $385.59M | $375.75M | $362.90M | $386.20M | $363.96M | $356.76M | $345.35M | $362.79M | $341.48M | $333.75M | $398.80M | $344.96M | $324.63M | $315.89M | $362.55M | $298.43M | $133.24M | $249.45M | $387.75M | $144.67M | $142.50M |
| High Forecast | $403.10M | $400.14M | $397.19M | $394.27M | $391.37M | $388.49M | $385.64M | $382.80M | $433.98M | $402.59M | $392.31M | $378.89M | $403.22M | $380.00M | $372.48M | $360.57M | $378.78M | $356.66M | $348.46M | $478.56M | $349.54M | $327.61M | $329.81M | $435.06M | $311.58M | $159.88M | $249.45M | $465.30M | $173.60M | $171.00M |
| Low Forecast | $380.08M | $377.28M | $374.51M | $371.75M | $369.02M | $366.30M | $363.61M | $360.94M | $409.19M | $379.59M | $369.91M | $357.25M | $380.19M | $358.29M | $351.20M | $339.98M | $357.15M | $335.41M | $328.56M | $319.04M | $343.44M | $311.29M | $310.97M | $290.04M | $293.78M | $106.59M | $249.45M | $310.20M | $115.73M | $114.00M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.97% | 0.88% | 0.87% | 0.79% | 0.94% | 2.35% | - | 0.61% | 1.50% | 1.60% |
NOV's average Quarter SG&A projection for Mar 24 is $398.80M, based on 4 Wall Street analysts, with a range of $319.04M to $478.56M. The forecast indicates a 18.69% rise compared to NOV last annual SG&A of $336.00M (Dec 23).
NOV EPS Forecast
| Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 9 | 19 | 18 | 9 | 8 | 8 | 12 | 16 | 18 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.52 | $0.29 | $0.39 | $0.32 | $0.27 | $0.08 | - | $-0.13 | $-0.11 | $-0.18 |
| Avg Forecast | $0.57 | $0.56 | $0.53 | $0.50 | $0.53 | $0.53 | $0.50 | $0.46 | $0.62 | $0.54 | $0.51 | $0.47 | $0.54 | $0.46 | $0.43 | $0.37 | $0.44 | $0.37 | $0.35 | $0.27 | $0.41 | $0.35 | $0.29 | $0.22 | $0.23 | $0.17 | $0.04 | $-0.05 | $-0.03 | $-0.08 |
| High Forecast | $0.60 | $0.59 | $0.56 | $0.53 | $0.56 | $0.56 | $0.53 | $0.49 | $0.65 | $0.57 | $0.54 | $0.49 | $0.57 | $0.49 | $0.45 | $0.40 | $0.47 | $0.47 | $0.37 | $0.29 | $0.44 | $0.48 | $0.31 | $0.23 | $0.24 | $0.18 | $0.04 | $-0.05 | $-0.03 | $-0.08 |
| Low Forecast | $0.55 | $0.55 | $0.52 | $0.49 | $0.52 | $0.52 | $0.49 | $0.45 | $0.60 | $0.53 | $0.50 | $0.46 | $0.53 | $0.45 | $0.42 | $0.37 | $0.43 | $0.32 | $0.34 | $0.26 | $0.38 | $0.29 | $0.29 | $0.22 | $0.22 | $0.16 | $0.04 | $-0.06 | $-0.03 | $-0.08 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.68% | 0.83% | 1.33% | 1.45% | 1.18% | 0.48% | - | 2.44% | 3.54% | 2.33% |
According to 4 Wall Street analysts, NOV's projected average Quarter EPS for Mar 24 is $0.27, with a low estimate of $0.26 and a high estimate of $0.29. This represents a -82.26% decrease compared to NOV previous annual EPS of $1.52 (Dec 23).
NOV Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| RES | RPC | $5.78 | $13.00 | 124.91% | Hold |
| WFRD | Weatherford | $91.53 | $164.00 | 79.18% | Buy |
| OIS | Oil States | $4.58 | $7.50 | 63.76% | Hold |
| SLB | Schlumberger | $39.96 | $58.67 | 46.82% | Buy |
| HAL | Halliburton Company | $27.87 | $38.46 | 38.00% | Buy |
| CHX | ChampionX | $28.60 | $38.33 | 34.02% | Buy |
| MRC | MRC Global | $12.19 | $16.00 | 31.26% | Buy |
| NOV | NOV | $15.86 | $19.00 | 19.80% | Buy |
| RNGR | Ranger Energy Services | $11.84 | $12.50 | 5.57% | Hold |
| WHD | Cactus | $56.38 | $54.00 | -4.22% | Hold |
| OII | Oceaneering | $23.20 | $21.00 | -9.48% | Buy |
| FTI | TechnipFMC | $24.25 | $20.88 | -13.90% | Buy |
NOV Forecast FAQ
Is NOV a good buy?
Yes, according to 8 Wall Street analysts, NOV (NOV) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 50.00% of NOV's total ratings.
What is NOV's price target?
NOV (NOV) average price target is $19 with a range of $12 to $29, implying a 19.80% from its last price of $15.86. The data is based on 8 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will NOV stock go up soon?
According to Wall Street analysts' prediction for NOV stock, the company can go up by 19.80% (from the last price of $15.86 to the average price target of $19), up by 82.85% based on the highest stock price target, and down by -24.34% based on the lowest stock price target.
Can NOV stock reach $20?
NOV's highest twelve months analyst stock price target of $29 supports the claim that NOV can reach $20 in the near future.
What are NOV's analysts' financial forecasts?
NOV's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $9.72B (high $10.15B, low $9.57B), average EBITDA is $279.99M (high $292.32M, low $275.63M), average net income is $805.47M (high $851.62M, low $789.18M), average SG&A $1.48B (high $1.55B, low $1.46B), and average EPS is $2.03 (high $2.15, low $1.99). NOV's analysts financial forecasts for the fiscal year (Dec 2028) are as follows: average revenue is $10.01B (high $10.45B, low $9.86B), average EBITDA is $288.38M (high $301.09M, low $283.89M), average net income is $857.44M (high $906.57M, low $840.09M), average SG&A $1.53B (high $1.59B, low $1.5B), and average EPS is $2.16 (high $2.28, low $2.12).
Did the NOV's actual financial results beat the analysts' financial forecasts?
Based on NOV's last annual report (Dec 2023), the company's revenue was $8.58B, beating the average analysts forecast of $8.42B by 1.91%. Apple's EBITDA was $651M, beating the average prediction of $274M by 137.59%. The company's net income was $993M, beating the average estimation of $341.98M by 190.37%. Apple's SG&A was $1.18B, missing the average forecast of $1.35B by -12.32%. Lastly, the company's EPS was $2.53, beating the average prediction of $1.28 by 98.14%. In terms of the last quarterly report (Dec 2023), NOV's revenue was $2.34B, beating the average analysts' forecast of $2.26B by 3.61%. The company's EBITDA was $161M, beating the average prediction of $65.13M by 147.20%. NOV's net income was $598M, beating the average estimation of $164.19M by 264.21%. The company's SG&A was $336M, missing the average forecast of $344.96M by -2.60%. Lastly, the company's EPS was $1.52, beating the average prediction of $0.414 by 267.52%